Tripathy et al. highlighted ALA as an MMP-9 and TGF-β activity inhibitor, consequently attenuating the cell invasion and metastasis of 4T1 and MDA-MB-231 breast cancer cells [25]. The gene discussed is MMP9; the disease is breast carcinoma.